KOUTIF THERAPEUTICS
Koutif Therapeutics is advancing discoveries from researchers at the University of Pittsburgh. Their academic founders are developing an inhibitor of E3 ligase Fbxo3, which is implicated in the pathogenesis of inflammatory conditions such as neuropathic pain, bronchiolitis obliterans syndrome, irritable bowel disease, chronic obstructive pulmonary disease, rheumatoid arthritis, and acute lung injury.
KOUTIF THERAPEUTICS
Industry:
Biotechnology Clinical Trials Health Care Therapeutics
Founded:
2017-01-01
Address:
Cleveland, Ohio, United States
Country:
United States
Website Url:
http://www.koutiftherapeutics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
600 K USD
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Microsoft Exchange Online Office 365 Mail Typekit Squarespace
Current Employees Featured
Founder
Official Site Inspections
http://www.koutiftherapeutics.com Semrush global rank: 5.32 M Semrush visits lastest month: 1.56 K
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
